期刊文献+

左卡尼丁对急性心肌损伤H-FABP、心肌酶及预后的影响 被引量:4

Influence of L-carnitine on H-FABP,Cardiac Enzymes and Prognosis in Patients with Acute Myocardial Injury
下载PDF
导出
摘要 目的:探讨左卡尼丁对急性心肌损伤的保护作用。方法:选择2013年6月-2014年4月入院临床诊断急性心肌梗死的76例患者为研究对象,将其分为对照组(常规治疗组)和试验组(左卡尼丁组)。对照组按心血管指南常规治疗,左卡尼丁组在此基础上加用左卡尼丁静滴。用药前后不同的时间段进行心型脂肪酸结合蛋白(H-FABP)、肌酸激酶同功酶(CK-MB)、肌钙蛋白I(c Tn I)等检查,并对两组间进行比较。观察左卡尼丁对急性心肌损伤的保护作用。结果:两组患者治疗前后各项指标比较差异均有统计学差异(P<0.05);组间比较治疗后各项指标,左卡尼丁组均明显低于常规治疗组,差异均有统计学差异(P<0.05)。治疗后试验组临床疗效明显优于对照组,差异均有统计学意义(P<0.05)。结论:左卡尼丁对患者急性心肌损伤有保护作用。 Objective:To study the protective effect of L-carnitine on the Acute Myocardial Injury.Method:In this study,76 patients with the Acute myocardial infarction were selected for clinical data for the hospitalization of Cardiology,randomly divided into left-carnitine treatment group(40 cases)and control group(36 cases).The control group was treated with conventional therapy,left carnitine treatment group on the basis of applications in the conventional left-carnitine therapy.Result:After treatment,H-FABP,CK-MB and cTnI in left-carnitine group was significantly lower than the control group,the difference were statistically significant(P<0.05).The clinical effect of L-carnitine group was significantly better than the control group,the difference were statistically significant(P<0.05).Conclusion:Left carnitine protection of patients with acute myocardial injury.
作者 杨林飞
出处 《中外医学研究》 2015年第23期39-41,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 左卡尼丁 急性心肌梗死 Left carnitine Acute myocardial infarction
  • 相关文献

参考文献6

二级参考文献22

  • 1刘秀华.钠钙交换体与心肌缺血再灌注[J].中国动脉硬化杂志,2005,13(2):233-235. 被引量:10
  • 2王虹.左卡尼丁对慢性肺心病的治疗作用[J].医学理论与实践,2006,19(7):749-750. 被引量:18
  • 3丁凌,许敏慧.生脉注射液辅助治疗急性心肌梗塞并发心源性休克临床观察[J].甘肃中医,2006,19(8):11-11. 被引量:6
  • 4王咏梅 殷仁富.中国产左旋卡尼丁治疗心绞痛的临床研究[J].国际心血管杂志,2001,3(1):30-32.
  • 5Ueland T, Jemtland R, Godang K, et al. Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction[J].J Am Coll Cardiol, 2004,44(10) : 1970.
  • 6Jackevicius CA, Alter D, Cox J, et al. Acute trealenl of myocardial infarction in Canada 1999 - 2002[J]. Can J Cardiol,2005,21 (2) : 145.
  • 7Caponnetto S, Canale C, Masperone MA, et al. Efficacy of L-propionylcamitine treatment in patients with left ventricular dysfunction [ J]. Eur Heart J, 1994, 15(9) : 1267.
  • 8Colonma P, Iliceto S. Myocardial infarction and left ventricular remodeling:results of the CEDIM trial [J]. Am Heart J,2000, 139(2 Pt 3): S124.
  • 9Salie R, Harper I, Cillie C, et al. Melatonin protects against ischemic-reperfusion myocardial damage[ J ]. J Mol Cell Cardial, 2001,33:343-357.
  • 10Ferrari R, Pepi P, Ferrari F, et al. Metabolic derangement in ischemic heart disease and its therapeutic control [ J ]. Am J Cardial, 1998,82(5A) :2K-13K.

共引文献29

同被引文献45

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部